Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

XXXXXXX

Xxxxxxxxxxxx zdravotnictví

ze dne 20. listopadu 2014

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx pro rok 2015

Xxxxxxxxxxxx zdravotnictví podle §80 xxxx. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx veřejného xxxxxx x o xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, ve znění xxxxxxxxxx předpisů, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx a mimořádná xxxxxxxx pro xxx 2015:

1. Antiqenní xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx

1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (DTaPHibVHBIPV):

Pertussis xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx

Xxxxxxxxx xxxxxxxxx externae xxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx anatoxinum xxx.

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B xxxxxxxxxxxxxx

Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 1

Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 2

Xxxxx xxxxxxxxxxxxxxx inactivatum typus 3

Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx influenzae x, Tetani xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx záškrtu, dávivému xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b ( DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx

Xxxxxx xxxxxxxxxx

Xxxxxxxx Xxxxxxxxxx pertussis

Pertussis xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum

Virus Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)

xxxxx 1 (Xxxxxxx)

xxxxx 2 (MEF-1)

typus 3 (Xxxxxxx)

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X

Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx

(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)

xxxxxxxxx xxx tetani xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxx, dávivému kašli (xxxxxxxxxx xxxxx), xxxxxx (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx anatoxinum ≥ 40 mezinárodních xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxxx xxxxxxxxx Hemofilem xxxxxxxxxx x (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx ........................................... min. 30 xxxxxxxxxxxxx jednotek

Tetani xxxxxxxxxx .................................................... xxx. 40 xxxxxxxxxxxxx jednotek

Pertussis xxxxxxxxxx (PT) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (XXX) .... 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) ................................................... 8 mikrogramů

Haemophilus xxxxxxxxxx X ....................................... 10 mikrogramů

cum xxxxxxxxx xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) očkovací xxxxx xxxxx nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:

1 dávka xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) očkovací xxxxx xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx ................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx B do 15 xxx xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X .......................... 10 mikrogramů

1g) xxxxxxxx látka xxxxx xxxxxx hepatitidě X xx 16 xxx x výše:

Antigenum tegiminis xxxxxxxxxxx X ........................... 20 mikrogramů

1h) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx xxxxx xxxxxxxxxx (Schwarz) xxx. 10^3,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx virus attenuatum (XXX 4385) min. 10^3,7 infekční dávka xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxx xxxxx xxxxxxxxxx (Wistar XX 27/3) min. 10^3,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu₅₀

1ch) xxxxxxxx xxxxx xxxxx xxxxxx přenosné xxxxx x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Mahoney) ........... 40 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ................ 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx D jednotek*

* xxxx množství xxxxxxxxxxxxxx xxxxxxxx stanovené xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.

1x) xxxxxxxx xxxxx proti xxxxxxx xxxxxxxxx Streptococcus xxxxxxxxxx v xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11 X, 12F, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23F, 33X ...... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx pneumokokovým infekcím:

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 5

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7F

Pneumococcale xxxxxxxxxxxxxxx sérotypus 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23F

1ka) xxxxxxxx látka proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):

Diphtheriae xxxxxxxxxx ............................... xx xxxx xxx 2 mezinárodní xxxxxxxx

Xxxxxx xxxxxxxxxx ........................................ xx méně xxx 20 mezinárodních xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx................................... 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx ... 8 mikrogramů

Pertaktin ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx) .............................. 40 X xxxxxxxx xxxxxxxx

xxxxx 2 (xxxx XXX-1) ................................... 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Xxxxxxx) ................................ 32 D xxxxxxxx xxxxxxxx

XXXX

1xx) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx ....................................... xxxx nebo xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Xx)

Xxxxxxxxx toxoid ....................................... více nebo xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Lf)

Pertusové xxxxxxxx:

Xxxxxxxxx xxxxxx ................................ 2,5 xxxxxxxxxx

Xxxxxxxxxxxx hemaglutinin ................. 5 xxxxxxxxxx

Xxxxxxx xxxx 2+3 ................................ 5 xxxxxxxxxx

Xxxxxxxxx ............................................. 3 xxxxxxxxxx

Xxxxx poliomyelitis xxxx 1 (inaktivovaný) ... 40 antigenních X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) ... 8 antigenních X jednotek

Virus poliomyelitis xxxx 3 (xxxxxxxxxxxx) ... 32 antigenních X jednotek

1l) xxxxxxxx xxxxx xxxxx tuberkulóze:

Mycobacterium xxxxx xxxxxxxxxx (XXX) xxxxxxx Xxxxxxx 1331 ... 0,75 xx&xxxx;≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx látka xxxxx virové xxxxxxxxxx X xxx xxxxx xxxxxxxx do dialyzačního xxxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid A (XXX) 50 xxxxxxxxxx x 1 dávce

2. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx zvláštní xxxxxxxx

2x) očkovací xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X 20 xxxxxxxxxx

2x) očkovací látka xxxxx xxxxxxxxx

Xxxxx xxxxxx xxxxxxxxxxx (xxxx Wistar xxxxxx PM/WI 38&xxxx;1503-3X xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 xxxxx (0,5 xx)

2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx pro xxxxxxx:

Xxxxxxxxx X virus xxxxxxxxxxx

3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxx

3x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X ve formuli xxx xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx A xx xxxxxxx pro děti:

Virus xxxxxxxxx X xxxxxxxxxxx

X xxxx 2015 x xxxxxxx na xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x očkování xxxxx xxxxxxxxx nemocem, nelze xxxxxxxx případnou úpravu xxxxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx látek ve Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Němeček, XXX, v. r.

Xxxxxxxxx

Xxxxxx xxxxxxx č. 278/2014 Xx. xxxxx xxxxxxxxx dnem 13.12.2014.

Xx xxx uzávěrky xxxxxx xxxxxxx xxxxx xxxxx xx xxxxxxxxx.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.